AbbVie Inc (ABBV)

Mexico
Currency in MXN
3,945.00
0.00(0.00%)
Delayed Data

ABBV Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa45,80456,19758,05454,31856,334
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+37.69%+22.69%+3.3%-6.44%+3.71%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa15,25717,31416,52716,72616,679
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa30,54738,88341,52737,59239,655
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+18.28%+27.29%+6.8%-9.48%+5.49%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa66.69%69.19%71.53%69.21%70.39%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa15,87019,12418,57019,93221,338
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+37.05%+20.5%-2.9%+7.33%+7.05%
aa.aaaa.aaaa.aaaa.aaaa.aa6,0036,8206,4877,0388,057
aa.aaaa.aaaa.aaaa.aaaa.aa9,86711,87212,08412,90413,288
aa.aaaa.aaaa.aaaa.aaaa.aa-432-1-10-7
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa14,67719,75922,95717,66018,317
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.02%+34.63%+16.19%-23.07%+3.72%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa32.04%35.16%39.54%32.51%32.51%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2,280-2,384-2,044-1,684-2,136
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-51.09%-4.56%+14.26%+17.61%-26.84%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-2,454-2,423-2,230-2,224-2,136
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa17439186540-
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa424-644510
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa12,43917,37920,90716,02016,691
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa--172--
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-7,129-3,803-6,834-9,651-11,914
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa3,39812,98913,4776,2503,716
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-59.67%+282.25%+3.76%-53.62%-40.54%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa7.42%23.11%23.21%11.51%6.6%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa-1,2241,4401,6321,377-570
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa4,62211,54911,8454,8734,286
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-6-7-9-10-8
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,61611,54211,8364,8634,278
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-41.44%+150.04%+2.55%-58.91%-12.03%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa10.08%20.54%20.39%8.95%7.59%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa60745443-
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,55611,46811,7824,8204,278
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.736.486.652.732.41
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-48.38%+137.06%+2.68%-59.02%-11.5%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.726.456.632.722.39
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-48.48%+137.13%+2.79%-58.97%-12.13%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,6671,7701,7711,7681,773
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,6731,7771,7781,7731,773
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa4.845.315.715.996.29
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.25%+9.71%+7.53%+4.9%+5.01%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa21,14828,28031,42426,35826,695.66
EBITDA Growth
aa.aaaa.aa